MAHSA MANA EMAM OD
Prescription History 1396202016
Optometrist in Mercer Island, WA

Active since February 28, 2019PECOS Enrolled
2448 76TH AVE SE STE 106, MERCER ISLAND, WA 98040(206) 232-1633(206) 232-2502 Get Directions

NPPES record last updated: October 27, 2023. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Record update history: Oct 27, 2023, Mar 11, 2019, Feb 28, 2019 (3 updates tracked since 2019).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MAHSA MANA EMAM OD, an active Optometrist specialist practicing in Mercer Island, WA. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 11 documented patient claims. Among these therapy options, the most frequently utilized medication is Azelastine Hcl, which accounts for 11 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
11
Total Claims
11
30-Day Fills
Azelastine Hcl
Most Prescribed · 11 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by MAHSA MANA EMAM OD in 2024, with prescription volumes, average cost per fill, and WA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other WA PrescribersVs. WA Avg
Azelastine Hcl11$33.66▼ Less than typical

About Azelastine Hcl: This medication is used to relieve nasal symptoms such as runny/itching/stuffy nose, sneezing, and post-nasal drip caused by allergies or other conditions. Show more ▾

Azelastine belongs to a class of drugs known as antihistamines. It works by blocking certain natural substances called histamines that are responsible for nasal symptoms. Azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia.

In 2024, this provider wrote 11 Medicare prescriptions for Azelastine Hcl, about a third of the volume of the typical Washington prescriber of this medication (28). Medicare paid an average of $33.66 per fill, versus $27.34 statewide.

How often this provider prescribes it

This provider
11
WA average
28.0

This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$33.66
WA average
$27.34

Gross Part D cost per fill; not the patient's out-of-pocket price.

11
30-Day Fills
standardized to 30-day supplies
308
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average WA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the WA average cost per fill.

About this data. The prescription history for MAHSA MANA EMAM OD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Mercer Island, WA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among WA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.